Business Description
Werewolf Therapeutics is a drug development company focused on harnessing the body's immune system to fight cancer and other immune-related diseases. Founded in 2017 and based in Watertown, Massachusetts, the company uses its proprietary PREDATOR platform to create molecules that only become active in the right biological environment, making treatments more targeted and reducing unwanted side effects. Its pipeline includes several experimental therapies aimed at advanced cancers and inflammatory conditions such as inflammatory bowel disease.
